The treatment of elderly patients with locally advanced or metastatic cutaneous squamous cell carcinoma using Cemiplimab monotherapy or Cemiplimab associated with palliative radiotherapy: A single centre experience from the United Kingdom

The treatment of elderly patients with locally advanced or metastatic cutaneous squamous cell carcinoma using Cemiplimab monotherapy or Cemiplimab associated with palliative radiotherapy: A single centre experience from the United Kingdom

Saved in:

Bibliographic Details
Main Authors:	A. del Carpio Barreda, A. Mcmillan, V. Bansal, C. Binns, P. Matteucci
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	EJC Skin Cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772611824002398
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cemiplimab Immunotherapy in the Treatment of Cutaneous Squamous Cell Carcinoma
by: Z. Kozéki, et al.
Published: (2024-01-01)

Combination of Cemiplimab and Radiotherapy in Advanced Squamous Cell Carcinoma
by: André Aparício Martins, et al.
Published: (2025-01-01)

High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
by: Dirk Schadendorf, et al.
Published: (2024-03-01)

Cemiplimab in the treatment of locally advanced cutaneous squamous cell carcinoma: a case series study
by: M.A. Pradeau, et al.
Published: (2024-01-01)

Efficacy and safety of cemiplimab in cutaneous squamous cell carcinoma on chronic wounds: A French retrospective study
by: M. Antoszczak, et al.
Published: (2024-12-01)

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
by: Dirk Schadendorf, et al.
Published: (2020-05-01)

A Novel Intersection: Cytomegalovirus Gastritis Following Cemiplimab and Talimogene Laherparepvec in a Patient With Advanced Cutaneous Squamous Cell Carcinoma
by: Goar Egoryan, et al.
Published: (2024-12-01)

Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma
by: Teresa Troiani, et al.
Published: (2025-01-01)

A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma
by: J. Kaczmar, et al.
Published: (2024-01-01)

A successful treatment of locally advanced squamous cell carcinoma with cemiplimab in a patient with multiple myeloma
by: M.C.C. Ferreira, et al.
Published: (2024-01-01)

Real-world data on tolerability and clinical response of cemiplimab in patients with advanced cutaneous squamous cell carcinoma: A retrospective, multicentre cohort study from the Netherlands
by: Maartje W. Rohaan, et al.
Published: (2023-01-01)

Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting
by: I. Ciobotariu, et al.
Published: (2024-01-01)

Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma
by: Vincenzo De Falco, et al.
Published: (2024-12-01)

Health‐related quality of life in patients with metastatic basal cell carcinoma treated with cemiplimab: Analysis of a phase 2 trial
by: Ketty Peris, et al.
Published: (2024-07-01)

Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress
by: S. Bhatia, et al.
Published: (2024-01-01)

Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab
by: Efterpi Zafiriou, et al.
Published: (2025-01-01)

Case report: Complete response of recurrent locally advanced basal cell carcinoma following addition of vismodegib to neoadjuvant cemiplimab therapy
by: Chalette Lambert-Swainston, et al.
Published: (2025-01-01)

Case report: Long term remission of metastatic sinonasal NUT carcinoma after palliative radiotherapy and immunotherapy in an elderly patient
by: Justin K. W. Ng, et al.
Published: (2025-01-01)

Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy
by: Robert M. Samstein, et al.
Published: (2014-01-01)

Swiss Recommendations for Systemic Therapies in Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma
by: Mirijam Nägeli, et al.
Published: (2021-06-01)

Pilomatrixoma of the parotid region: A benign tumor mimicking metastatic cutaneous squamous cell carcinoma
by: Nikita Grieder, MD, et al.
Published: (2025-04-01)

Management and outcomes following the first cutaneous squamous cell carcinoma in kidney transplant recipients: the United Kingdom COAST (Contemporary Outcomes After cutaneous SCC in Transplant recipients) study
by: E. Peleva, et al.
Published: (2024-01-01)

Advancing immunotherapy in recurrent or metastatic head and neck cutaneous squamous cell carcinoma: The imperative for rigorous clinical trials
by: B. Haridevamuthu, et al.
Published: (2024-06-01)

Outcome of radiotherapy for metastatic neuroblastoma
by: Noor Muhammed Abdulrahaman, et al.
Published: (2024-09-01)

TAS-102 Monotherapy and Combination Therapy with Bevacizumab for Metastatic Colorectal Cancer
by: Cheng-Jiang Liu, et al.
Published: (2021-01-01)

Cutaneous Manifestation of Metastatic Infantile Choriocarcinoma
by: Timothy Brooks, et al.
Published: (2014-01-01)

Feasibility planning study of lattice radiotherapy for palliation in bulky tumors
by: Jayashree NP, et al.
Published: (2024-12-01)

A Patient-Relevant Measurement Strategy to Assess Clinical Benefit of Novel Therapies for Non-metastatic Cutaneous Squamous Cell Carcinoma
by: Diana Rofail, et al.
Published: (2024-10-01)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Vivek V. Gurudutt, et al.
Published: (2011-01-01)

Innovations in radiotherapy for tongue squamous cell carcinoma
by: Songling Hu, et al.
Published: (2024-11-01)

Primary Cutaneous Cryptococcosis Treated with Debridement and Fluconazole Monotherapy in an Immunosuppressed Patient: A Case Report and Review of the Literature
by: Jennifer Wang, et al.
Published: (2015-01-01)

Exploring the experiences of children's palliative care for forced migrant families in the United Kingdom: an interpretative phenomenological study
by: Marie Clancy, et al.
Published: (2025-01-01)

Possibilities of palliative chemotherapy in patients with locally advanced and metastatic pancreatic cancer
by: L. I. Moskvicheva, et al.
Published: (2020-12-01)

Outcomes of patients receiving urgent palliative radiotherapy for advanced lung cancer: an observational study
by: Yang Xu, et al.
Published: (2024-12-01)

High Fracture Risk of Femoral Bone Metastasis Treated with Palliative Radiotherapy in Recent Years
by: Kenji Makita, et al.
Published: (2024-11-01)

Outcomes of Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma
by: Nichole R. Dean, et al.
Published: (2011-01-01)

Paraneoplastic bullous pemphigoid secondary to cutaneous squamous cell carcinoma
by: Karolina Zarańska, et al.
Published: (2025-01-01)

Cutaneous Squamous Cell Carcinoma with Invasion through Ear Cartilage
by: Julie Boisen, et al.
Published: (2016-01-01)

Clinical Risk Factors for Cutaneous Squamous Cell Carcinoma in Patients with Actinic Keratosis or Cutaneous Squamous Cell Carcinoma in Situ: A Retrospective Double-cohort Study
by: Jaakko S. Knuutila, et al.
Published: (2024-11-01)

Trends in utilization of first‐line palliative treatments for anal squamous cell carcinoma
by: Srinidhi J. Radhakrishnan, et al.
Published: (2023-02-01)